arrow
J

Johan A F Koekkoek

leiden university medical center
H指数:28
被引数:2,366

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health-Related Quality of Life in Glioma Subtypes: A Pooled Analysis of 16 Randomized Trials from the CODAGLIO 2.0 project

胶质瘤亚型相关的健康生活质量:CODAGLIO 2.0项目16项随机试验的合并分析

2026-10-010
OAAI
Feasibility of Spin- and Gradient-Echo Dynamic Susceptibility Contrast MRI for Microvascular Characterization at 7 Tesla

利用7特斯拉下自旋回波和梯度回波动态对比度MRI对微血管进行表征的可行性

2026-09-220
OAAI
Association between temozolomide-related hematologic toxicity and health-related quality of life (HRQoL) in patients with newly diagnosed glioblastoma

替莫唑胺相关血液学毒性与新诊断胶质母细胞瘤患者健康相关生活质量(HRQoL)的关联

2026-09-080
PRE
Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: an analysis of 5 closed EORTC trials

EORTC QLQ-C30总结评分对总生存期的预后价值:对5项已完成的EORTC试验的分析

2026-04-300
OAAI
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis

年龄和性别作为胶质瘤患者健康相关生活质量结果的风险因素:CODAGLIO 2.0分析

2026-03-010
OA
Health-Related Quality of Life in Adolescents and Young Adults With an Uncertain or Poor Cancer Prognosis: Quantitative Baseline Results of the CORD-AYA Study

癌症预后不确定或不良的青少年和年轻成年人的健康相关生活质量:CORD-AYA研究的定量基线结果

2025-11-210
OAAI
Health-Related Quality of Life in Molecular Glioma Subtypes: A Pooled Analysis from 16 Randomized Trials

分子胶质瘤亚型的健康相关生活质量:一项来自16项随机试验的合并分析

2025-11-010
OAAI
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes

EORTC QLQ-C30总结评分在癌症研究中的应用及其与EORTC QLQ-C30总体健康/生活质量量表性能的比较:一项效应量的系统评价和比较分析

2025-10-260
OAAI
Chemotherapy in adult patients with pilocytic astrocytoma: a retrospective multicenter cohort study

成人毛细胞型星形细胞瘤患者的化疗:一项回顾性多中心队列研究

2025-10-150
OA
BEVACIZUMAB VERSUS DEXAMETHASONE AS FIRST-LINE TREATMENT FOR SYMPTOMATIC CEREBRAL RADIATION NECROSIS AFTER RADIATION OF HIGH GRADE GLIOMA OR BRAIN METASTASES: A RANDOMIZED CLINICAL TRIAL

贝伐珠单抗与地塞米松作为高分级胶质瘤或脑转移瘤放射治疗后症状性脑放射性坏死的初始治疗:一项随机临床试验

2025-10-010
OAAI
B THE USE OF EORTC QLQ-C30 SUMMARY SCORE IN CANCER CLINICAL TRIALS AND ITS PERFORMANCE AS COMPARED WITH THE GLOBAL HEALTH / QUALITY OF LIFE SCALE: A COMPARATIVE ANALYSIS OF EFFECT SIZES

B 癌症临床试验中EORTC QLQ-C30总结评分的应用及其与全球健康/生活质量量表性能的比较:效应量比较分析

2025-10-010
OA
Challenges in interpreting individual-level changes in health-related quality of life in patients with glioma using minimally important differences (MIDs) and a 4-point Likert scale

使用最小临床重要差异(MIDs)和4点李克特量表解释胶质瘤患者健康相关生命质量个体层面变化所面临的挑战

2025-08-050
OA